Clinical Trials Browser

Phase 2 × Aggression × Topotecan × Clear all

NCT00038545 2018-10-30

A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Phase 2 Completed

Aggression, Lymphoma, Lymphoma, Non-Hodgkin